SmartPill Diagnostics, Inc. Capsule Clinical Trials Are Set To Begin At The University of Louisville
10/19/2005 5:10:11 PM
BUFFALO, N.Y.--(BUSINESS WIRE)--May 12, 2005--The SmartPill Corporation (www.smartpillcorp.com), developer of the SmartPill Capsule, an ingestible medical device that captures biomedical data from within a patient's GI tract, today announced that clinical trials of its SmartPill ACT-I Capsule and GI Monitoring System are expected to begin the week of May 23rd at the University of Louisville (Louisville, KY), bringing to five the number of sites participating in SmartPill clinical trials.
A total of 20 subjects, 14 Normals and six Gastroparetics, are expected to participate in the clinical research study. The principal investigator is John M. Wo, M.D., Associate Professor and Director of the Swallowing and Motility Center, and of the Clinical Research Unit, University of Louisville Department of Medicine, Division of Gastroenterology/Hepatology. The primary objective of the study is to demonstrate the correlation of gastric residence times measured by the SmartPill ACT-I Capsule and conventional scintigraphy.
comments powered by